[ Price : $8.95]
Federal Register notice: FDA announces an 11/17 public workshop entitled Quantitative Brain Amyloid PET Imaging in Patients with A...[ Price : $8.95]
The International Council for Harmonization posts a presentation outlining its finalized guidance entitled A Selective Approach to...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled In Vitro Permeation Test Studies for Topical Products Submi...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Physicochemical and Structural (Q3) Characterization of Top...[ Price : $8.95]
Janssen Pharmaceutical says new data show that patients given Tremfya (guselkumab) saw a clinical response rate of about 80% in tr...[ Price : $8.95]
Responding to a petition seeking the removal of approval for Jazz Pharmaceuticals lung cancer drug Zepzelca, FDA explains why it d...[ Price : $8.95]
FDA gives accelerated approval to Janssens teclistamab-cqyv for some adults with relapsed or refractory multiple myeloma.[ Price : $8.95]
FDA medical reviewers tell members of the Cardiovascular and Renal Drugs Advisory Committee there are safety concerns with GlaxoSm...